Literature DB >> 31019062

IL-21 Enhances the Development of Colitis-Associated Colon Cancer: Possible Involvement of Activation-Induced Cytidine Deaminase Expression.

Akemi Araki1, Lianjin Jin1, Hidetoshi Nara1, Yuji Takeda1, Nobuhito Nemoto1,2, Md Yeashin Gazi1, Hironobu Asao3.   

Abstract

Inflammatory bowel diseases are known to be the origin of colitis-associated colon cancer (CAC). We previously reported that dextran sulfate sodium (DSS)-induced colitis is exacerbated in mouse-IL-21-isoform transgenic (Tg) mice. In this study, we assessed the CAC development induced by azoxymethane (AOM) and DSS in our Tg mice. AOM-DSS-induced tumor development was dramatically increased in the Tg mice compared with wild-type mice. IL-21 is known to enhance activation-induced cytidine deaminase (AID) expression in B cells and induce Ab class switching. In contrast, the AID expression in cells other than B cells initiates tumor development in many tissues. Therefore, we investigated whether IL-21 induces the AID expression in the large intestinal epithelial cells (IECs) during CAC development. AID gene and protein expression was increased in the IECs of AOM-DSS- or DSS-treated Tg mice compared with those of wild-type mice. Furthermore, we confirmed IL-21 induced AID gene expression in the purified IECs ex vivo. The present study also showed IL-21R gene expression in unstimulated wild-type mouse IECs, and this gene expression was augmented by TNF-α stimulation. The IL-21R expression and IL-21-induced AID gene activation were further confirmed in the Colon-38 cell line. Taken together, IL-21 may be involved in increasing the risk of CAC by enhancing the AID expression in IECs.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31019062     DOI: 10.4049/jimmunol.1800550

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AID.

Authors:  Ping Zhang; Mengting Qin; Yang Wang; Xiaodong Chen; Yinsha Miao; Meng Yuan; Wen Zhou; Dandan Li; Dan Wang; Mengying Wang; Li Ai; Yunfeng Ma; Yanying Dong; Yanhong Ji
Journal:  Blood Adv       Date:  2022-07-12

Review 2.  The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma-Recent Findings and Review.

Authors:  Jędrzej Borowczak; Krzysztof Szczerbowski; Mateusz Maniewski; Adam Kowalewski; Marlena Janiczek-Polewska; Anna Szylberg; Andrzej Marszałek; Łukasz Szylberg
Journal:  Biomedicines       Date:  2022-07-11

Review 3.  Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention.

Authors:  Wenqian Li; Tiantian Zhao; Dacheng Wu; Jiajia Li; Mei Wang; Yunyun Sun; Sicong Hou
Journal:  Curr Oncol       Date:  2022-08-25       Impact factor: 3.109

Review 4.  Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.

Authors:  Ross J Porter; Mark J Arends; Antonia M D Churchhouse; Shahida Din
Journal:  J Crohns Colitis       Date:  2021-12-18       Impact factor: 9.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.